DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18351
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Gautam-
dc.date.accessioned2025-03-12T08:53:57Z-
dc.date.available2025-03-12T08:53:57Z-
dc.date.issued2023-11-
dc.identifier.urihttps://www.tandfonline.com/doi/abs/10.4155/tde-2023-0076-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/jspui/handle/123456789/18351-
dc.description.abstractAccording to estimates, up to 25% of the world’s population has fungal skin diseases, making them the most prevalent infectious disease. Several chemical classes of antifungal drugs are available to treat fungal infections. However, the major challenges of conventional formulations of antifungal drugs include poor pharmacokinetic profiles like solubility, low permeability, side effects and decreased efficacy. Novel drug delivery is a promising approach for overcoming pharmacokinetic limitations and increasing the effectiveness of antibiotics. In this review, we have shed light on microemulsions, nanoemulsions, and emulgels as novel drug delivery approaches for the topical delivery of antifungal antibiotics. We believe these formulations have potential translational value and could be developed for treating fungal infections in humans.en_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.subjectPharmacyen_US
dc.subjectNanoemulsionsen_US
dc.subjectEmulgelen_US
dc.subjectDrug deliveryen_US
dc.titleMicroemulsions, nanoemulsions and emulgels as carriers for antifungal antibioticsen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.